Welcome to Kidney Cancer Care

Welcome to the McMaster University - St. Joseph’s Healthcare Kidney Cancer Centre of Excellence (KCCE) website. This is a patient-oriented portal providing information and links regarding the cutting edge management of kidney cancer. Here you will find up-to-date information about kidney cancer and its treatment, recent advances in management, current clinical research information, and links to our basic science research program. We hope you find this website informative and useful and we welcome your feedback.

Anil Kapoor, MD, FRCSC
Director
McMaster – SJH Kidney Cancer Centre of Excellence (KCCE)

Get the Flash Player to see this player.

What’s new in Kidney Cancer Care

Neutrophil-to-Lymphocyte Ratio May Be Associated With mRCC Outcomes

April 26, 2012

Two recent studies have reported on the possible utility of assessing pre-treatment neutrophil-to-lymphocyte ratio (NLR) as a prognostic factor in mRCC.

Tandutinib Not Effective For mRCC

April 26, 2012

A small phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases (FLT3), has concluded that the novel agent has no clinical activity and excessive toxicity, and should not be developed further for mRCC.

Low Recurrence And Cancer Death Rates Associated With Kidney Cancer Subtype

March 31, 2012

Patients with papillary renal cell carcinoma, the second most common kidney cancer subtype, face a low risk of tumour recurrence and cancer-related death after surgery.